EUVIMEDOpdag EUVIMED
Crossref

18 F ‐Florzolotau PET Imaging Unveils Tau Pathology in Dementia with Lewy Bodies

Gan Tang iD, Jia-Ying Lu iD, Xin-Yi Li iD, Rui-Xin Yao, Yu-Jie Yang, Fang-Yang Jiao, Ming-Jia Chen, Xiao-Niu Liang iD, Zi-Zhao Ju, Jing-Jie Ge, Yi-Xin Zhao, Bo Shen and 10 more

Movement Disorders · 2025-01 · 40 (1) · 108-120

DOI: 10.1002/mds.30055 ↗

At a glance

Journal article in Movement Disorders, published online on 2024-11-18. Written by Gan Tang and 21 co-authors. Institution: Department of Neurology, National Research Center for Aging and Medicine, National Center for Neurological Disorders, and State Key Laboratory of Med…. Major MEDLINE topics: Lewy Body Disease, Positron-Emission Tomography, tau Proteins, Alzheimer Disease. Cited 7 times so far (Crossref); 70 references. Funded by: Clinical Research Project of Huashan Hospital, Fudan University, National Natural Science Foundation of China, National Ministry of Science and Technology grant.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Dementia with Lewy bodies (DLB) commonly exhibits a complex neuropathology, sharing characteristics with Alzheimer's disease (AD), including tau aggregates. However, studies using the 18 F‐AV‐1451 tau tracer have shown inconsistent findings regarding both the extent and topographical distribution of tau pathology in DLB.

Objectives

Our aim was to elucidate the topographical patterns of tau deposition in DLB and to investigate the in vivo pathological distinction between DLB and AD in virtue of the 18 F‐Florzolotau positron emission tomography (PET) imaging.

Methods

This cross‐sectional study enrolled patients with DLB (n = 24), AD (n = 43), and cognitively healthy controls (n = 18). Clinical assessments and 18 F‐Florzolotau PET imaging were performed. 18 F‐Florzolotau binding was quantitatively assessed on PET images using standardized uptake value ratios and voxel‐wise analysis.

Results

18 F‐Florzolotau PET imaging revealed widespread tau deposition across various cortical regions in DLB, uncovering heterogeneous topographical patterns. Among patients, 54.17% showed patterns similar to AD, whereas 16.67% exhibited distinct patterns. Compared to AD, DLB exhibited a unique in vivo neuropathological profile, characterized by a lower tau protein burden, heterogeneous topographical distributions, and a specific role of the medial temporal lobe in tau pathology.

Conclusions

18 F‐Florzolotau PET imaging elucidated tau pathology patterns in DLB, providing valuable insights for future in vivo pathological differentiation and potential disease‐modifying therapies. © 2024 International Parkinson and Movement Disorder Society.

Subjects

MeSH terms (MEDLINE)

Lewy Body DiseasePositron-Emission Tomographytau ProteinsAlzheimer DiseaseCarbolinesBrainHumansMaleAgedFemaleCross-Sectional StudiesAged, 80 and overMiddle Aged

Author keywords

18F‐FlorzolotauAlzheimer's diseasedementia with Lewy bodiespositron emission tomographytau

Substances

tau Proteins7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indoleCarbolines

Authors and institutions

  • Department of Neurology, National Research Center for Aging and Medicine, National Center for Neurological Disorders, and State Key Laboratory of Medical Neurobiology, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Nuclear Medicine and PET Center, National Center for Neurological Disorders, and National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
  • Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Medicine, Tongji University, Shanghai, China.
  • Institute of Neurology, Fudan University, Shanghai, China.
  • APRINOIA Therapeutics, Suzhou, China.
  • MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China.

ORCID profiles: Gan Tang, Jia-Ying Lu, Xin-Yi Li, Xiao-Niu Liang, Ping Wu, Jian-Jun Wu, Chuantao Zuo, Jian Wang, Feng-Tao Liu

Funding

  • Clinical Research Project of Huashan Hospital, Fudan University
  • National Natural Science Foundation of China
  • National Ministry of Science and Technology grant
  • Scientific and Technological Innovation (STI) 2030-Major Project

Cite

APA

Tang, G., Lu, J. Y., Li, X. Y., Yao, R. X., Yang, Y. J., Jiao, F. Y., Chen, M. J., Liang, X. N., Ju, Z. Z., Ge, J. J., Zhao, Y. X., Shen, B., Wu, P., Sun, Y. M., Wu, J. J., Yen, T. C., Zuo, C., Wang, J., Zhao, Q. H., …, & Shanghai Memory Study (SMS) and Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI) (2025). 18 F ‐Florzolotau PET Imaging Unveils Tau Pathology in Dementia with Lewy Bodies. Movement Disorders, 40(1), 108-120. https://doi.org/10.1002/mds.30055

Vancouver

Tang G, Lu JY, Li XY, Yao RX, Yang YJ, Jiao FY, et al. 18 F ‐Florzolotau PET Imaging Unveils Tau Pathology in Dementia with Lewy Bodies. Movement Disorders. 2025;40(1):108-120. doi:10.1002/mds.30055

BibTeX
@article{Tang2025,
  author = {Tang, Gan and Lu, Jia-Ying and Li, Xin-Yi and Yao, Rui-Xin and Yang, Yu-Jie and Jiao, Fang-Yang and Chen, Ming-Jia and Liang, Xiao-Niu and Ju, Zi-Zhao and Ge, Jing-Jie and Zhao, Yi-Xin and Shen, Bo and Wu, Ping and Sun, Yi-Min and Wu, Jian-Jun and Yen, Tzu-Chen and Zuo, Chuantao and Wang, Jian and Zhao, Qian-Hua and Zhang, Hui-Wei and Liu, Feng-Tao and Shanghai Memory Study (SMS) and Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI), Shanghai Memory Study (SMS) and Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI)},
  title = {18 F ‐Florzolotau PET Imaging Unveils Tau Pathology in Dementia with Lewy Bodies},
  journal = {Movement Disorders},
  year = {2025},
  volume = {40},
  number = {1},
  pages = {108--120},
  doi = {10.1002/mds.30055}
}
Start for free →